Depomed Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (43)

View All

Latest Posts

About This Stock More About This Stock
Concern Over Valeant's Financial Controls 'Likely Just Noise,' Says Cantor
Article By: The Fly
Friday, October 13, 2017 8:17 PM EDT
Cantor Fitzgerald analyst Louise Chen says after speaking with the company, she believes the concerns are "likely just noise and cannot be strung together into an argument" that Valeant has issues with financial controls.
In this article: VRX Also: DEPO
Read
Why I'm Interested In PDL BioPharma
Article By: Kate Hayden
Wednesday, August 9, 2017 10:36 PM EDT
Satisfying my curiosity as to what happened to some venture-backed companies, in this case one called ESP Pharma. Its acquirer hit a rough patch but may be looking up.
In this article: PDLI Also: VRX, DEPO
Read
Morning Call For Tuesday, August 8
Article By: Jim Van Meerten
Tuesday, August 8, 2017 7:50 AM EDT
Sep E-mini S&Ps (ESU17 -0.10%) this morning are down -0.05% on concern a slowdown in global trade will weaken economic growth.
In this article: BKD, BZH, CAR, IPHI, MTW, THC, VG, DEPO, AMZN, CHRS, ESNT, FGEN, MYOK, TWLO, QTNA
Read
PDL BioPharma Is A Solid Biotech Investment In A Friendly Regulatory Environment
Article By: White Diamond Research
Monday, July 10, 2017 3:38 PM EDT
Despite reaching a low in its downtrend, PDL expects to remain profitable, has a large cash position, and a share buyback is in place.
In this article: PDLI Also: VRX, DEPO, IBB, HZNP, PRGO, NVS
Read
Morning Call For Monday, July 10
Article By: Jim Van Meerten
Monday, July 10, 2017 8:29 AM EDT
Sep E-mini S&Ps (ESU17 +0.02%) this morning are up +0.12% and European stocks are up +0.42%. Strength in technology stocks is leading the overall market higher with Advanced Micro Devices and Nvidia both up over 1% in pre-market trading.
In this article: AIV, COL, HPQ, JNPR, LMT, DEPO, USAT, COST, INTC, NVDA, XLNX, FIVE, LC, PYPL
Read
All Posts

Latest Tweets for $DEPO

No tweets yet!

PARTNER HEADLINES

$DEPO

Comments Status Updates
Buy These 3 Undervalued Biotech Stocks Ready To Breakout
Susan Alter • 6/8/2015 7:45:54 PM

Great article. What's your take on $DEPO? Have you seen it's chart for Monday? I think it might be a hidden gem. All their drugs own market thru 2022 and Nucynta will be.5 bill.

1 to 1 of 1 comments